His main research concerns Internal medicine, Endocrinology, Cushing syndrome, Basal and Met-enkephalin. Much of his study explores Endocrinology relationship to Chemotherapy. The various areas that G. M. Besser examines in his Cushing syndrome study include Cushing's disease, Nelson's syndrome, Abdomen, Adipose tissue and Adrenocorticotropic hormone.
His biological study spans a wide range of topics, including Cortisol awakening response, Antagonist, Blood pressure, Differential diagnosis and Opiate. His Met-enkephalin research is multidisciplinary, relying on both beta-Endorphin and Cerebrospinal fluid. His Cerebrospinal fluid study incorporates themes from Anesthesia and Radioimmunoassay.
G. M. Besser mainly investigates Internal medicine, Endocrinology, Hormone, Prolactin and Acromegaly. His works in Bromocriptine, Growth hormone secretion, Hydrocortisone, Growth hormone and Growth hormone–releasing hormone are all subjects of inquiry into Internal medicine. Cushing syndrome, Somatostatin, Hypothalamus, Anterior pituitary and Peptide hormone are the subjects of his Endocrinology studies.
G. M. Besser has researched Hormone in several fields, including Radioimmunoassay and Chemotherapy. His Prolactin research includes elements of Sex hormone-binding globulin, Secretion, Dopamine and Follicle-stimulating hormone. His Acromegaly research is multidisciplinary, incorporating perspectives in Insulin and Octreotide.
His primary areas of investigation include Internal medicine, Endocrinology, Acromegaly, Cushing syndrome and Pegvisomant. G. M. Besser frequently studies issues relating to Gastroenterology and Internal medicine. His Endocrinology study integrates concerns from other disciplines, such as Differential diagnosis and Pediatrics.
His Acromegaly study also includes fields such as
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Acromegaly, Cushing syndrome and Pegvisomant. His Cortisone, Hydrocortisone, Sex hormone-binding globulin, Hormone replacement therapy and Randomized controlled trial investigations are all subjects of Internal medicine research. G. M. Besser studies Endocrinology, focusing on Growth hormone deficiency in particular.
The Acromegaly study combines topics in areas such as Multimodal therapy, Polymenorrhea, Gonadotropin deficiency, Complication and Reproductive age. His Cushing syndrome study combines topics in areas such as Steatosis, hirsutism, Female patient, Dexamethasone suppression test and Adipose tissue. As a part of the same scientific study, G. M. Besser usually deals with the Pegvisomant, concentrating on Somatostatin and frequently concerns with Pancreatic polypeptide, Insulin, Impaired glucose tolerance and Glucose tolerance test.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
J.D. Carpten;C.M. Robbins;A. Villablanca;L. Forsberg.
Nature Genetics (2002)
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
D. Trump;B. Farren;C. Wooding;J.T. Pang.
QJM: An International Journal of Medicine (1996)
HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MAN
W.A Stubbs;A Jones;C.R.W Edwards;G Delitala.
The Lancet (1978)
INCREASED β-ENDORPHIN BUT NOT MET-ENKEPHALIN LEVELS IN HUMAN CEREBROSPINAL FLUID AFTER ACUPUNCTURE FOR RECURRENT PAIN
Vicky Clement-Jones;Vicky Clement-Jones;Susan Tomlin;Susan Tomlin;LesleyH. Rees;LesleyH. Rees;Lorraine Mcloughlin;Lorraine Mcloughlin.
The Lancet (1980)
Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1
J.H.D. Bassett;S.A. Forbes;A.A.J. Pannett;S.E. Lloyd.
American Journal of Human Genetics (1998)
Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine
G. M. Besser;Lynne Parke;C. R. W. Edwards;Isabel A. Forsyth.
DIAGNOSIS AND MANAGEMENT OF ACTH‐DEPENDENT CUSHING'S SYNDROME: COMPARISON OF THE FEATURES IN ECTOPIC AND PITUITARY ACTH PRODUCTION
T. A. Howlett;P. L. Drury;L. Perry;I. Doniach.
Clinical Endocrinology (1986)
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
J. A. Verhelst;P. J. Trainer;T. A. Howlett;L. Perry.
Clinical Endocrinology (1991)
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
S H Pearce;D Trump;C Wooding;G M Besser.
Journal of Clinical Investigation (1995)
Transsphenoidal resection in Cushing's disease : undetectable serum cortisol as the definition of successful treatment
P. J. Trainer;H. S. Lawrie;J. Verhelst;T. A. Howlett.
Clinical Endocrinology (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: